United Kingdom· GB-APID-34162411000001109

FibCLOT 1.5g powder and solvent for solution for infusion vials

A medicinal product containing fibrinogen human, registered in United Kingdom by LFB Biopharmaceuticals Ltd.

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fibrinogen humanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Fibrinogen human
Manufacturer: LFB Biopharmaceuticals Ltd
Country: United Kingdom (GB)
ATC code: —
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 2

gtin
3700386800153
gtin
03700386800153

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fibrinogen human in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fibrinogen human products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Fibclot, Fibryga
Belgium · Fibclot, Fibryga
Bulgaria · Fibryga, Хемокомплетан P
Cyprus · Fibryga, Riastap
Czechia · Fibryga, Haemocomplettan P
Germany · Fibclot, Fibryga
Denmark · Fibclot, Fibryga
Estonia · Fibryga
Spain · Fibclot, Fibryga
Finland · Fibclot, Fibryga
France · Clottafact, Fibryga
Greece · Fibclot, Riastap
Croatia · Fibryga
Hungary · Fibclot, Fibryga
Ireland · Fibryga, Riastap
Iceland · Fibryga, Riastap
Italy · Fibriclotte, Fibryga
Lithuania · Fibryga
Luxembourg · Fibclot, Fibryga
Latvia · Fibryga
Malta · Fibryga, Riastap
Netherlands · Fibclot, Fibryga
Norway · Fibclot, Fibryga
Poland · Fibryga, Riastap
Portugal · Fibryga, Haemocomplettan
Romania · Fibryga, Haemocomplettan P
Sweden · Fibclot, Fibryga
Slovenia · Fibrema, Prufibry
Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e28fc44e-64f9-4862-96f3-af7a76bcd5ec
GET /v1/drugs/e28fc44e-64f9-4862-96f3-af7a76bcd5ec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "34162411000001109",
  "desc": "FibCLOT 1.5g powder and solvent for solution for infusion vials (LFB Biopharmaceuticals Ltd)",
  "form": "Powder and solvent for solution for infusion",
  "vpid": "34162211000001105",
  "source": "dmd",
  "vtm_id": "776201000",
  "strength": "1.5 gram",
  "substance": "Fibrinogen human",
  "ingredient": "Human fibrinogen",
  "supplier_code": "23638411000001104"
}

API reference MCP server Plans

See everything about fibrinogen human.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console